Latest News and Press Releases
Want to stay updated on the latest news?
-
BOTHELL, WA--(Marketwire - July 14, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today the appointment of Peter S. Garcia as Chief Financial Officer and Secretary, reporting to the President and CEO....
-
MDRNA, Inc. Regains Full Compliance With All Marketplace Rules to Remain on the NASDAQ Global Market
BOTHELL, WA--(Marketwire - June 23, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that on June 22, 2009, it received a letter from The NASDAQ Stock Market, LLC notifying the Company that it has...
-
BOTHELL, WA--(Marketwire - June 19, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that it now has full financial and transactional control over the use of its proprietary UNA (Unlocked...
-
BOTHELL, WA--(Marketwire - June 16, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that it has repaid all of its remaining debt to General Electric Capital Corporation (GECC) under the January...
-
BOTHELL, WA--(Marketwire - June 12, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that it has closed its previously announced sale of 5.25 million shares of its common stock and warrants to...
-
BOTHELL, WA--(Marketwire - June 11, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that on Wednesday, June 10, 2009, the NASDAQ Hearings Panel granted the request of the Company to remain listed...
-
BOTHELL, WA--(Marketwire - June 10, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that it entered into definitive agreements on June 9, 2009 with existing investors to raise gross proceeds of...
-
BOTHELL, WA--(Marketwire - June 9, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that it has obtained full U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug...
-
BOTHELL, WA--(Marketwire - June 8, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today in vivo data from a bladder cancer model demonstrating effective localized delivery of a UsiRNA to a solid tumor,...
-
BOTHELL, WA--(Marketwire - May 26, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that it has received a letter from the Listing Qualifications Department of The NASDAQ Stock Market notifying the...